COVID-19

O acervo do Cannabis Indica reúne 119 estudos científicos que tocam a condição COVID-19, publicados entre 1998 e 2024. Pela leitura automatizada, 85 (71%) foram classificados como favoráveis, 22 (18%) como inconclusivos e 12 (10%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (67 estudos), seguido de estudo laboratorial (25). Os compostos mais presentes são Palmitoiletanolamida (PEA), Endocanabinoide (não especificado) e Anandamida (AEA). Aparece com frequência ao lado de Inflamação, Ansiedade e Câncer.

Estudos indexados: 119
Período coberto: 1998–2024
Favoráveis: 85 · 71%
Inconclusivos: 22 · 18%
Desfavoráveis: 12 · 10%
Termo original: COVID-19

O acervo em números

Tipo de estudo

Metanálise67

Estudo Laboratorial25

Estudo em Animais11

Ensaio Clínico10

Ensaio Clínico Duplo-Cego5

Metanálise Clínica1

Direção do resultado

Favorável85

Inconclusivo22

Desfavorável12

Por década

1990s1

2000s1

2020s117

Aparece junto com

Inflamação34 Ansiedade13 Câncer11 Estresse11 Síndrome do Desconforto Respiratório Agudo11 Depressão10 Dependência Química9 Dependência — Cannabis8

119 estudos

Filtrar e buscar no acervo →

2024
A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome
FavorávelEnsaio ClínicoÔmega-3 Ômega-6
2024
Palmitoylethanolamide and Luteolin for postinfectious olfactory disorders: How clinically meaningful is its effect?
FavorávelEnsaio ClínicoEstresse Síndrome do Desconforto Respiratório Agudo Vírus Sincicial Respiratório Palmitoiletanolamida (PEA)
2023
Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome
FavorávelEnsaio Clínico Duplo-CegoInflamação Disfunção Cognitiva Estresse Oxidativo 2-Araquidonoilglicerol (2-AG)Palmitoiletanolamida (PEA)
2023
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies
FavorávelMetanáliseInflamação Depressão Palmitoiletanolamida (PEA)
2023
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
FavorávelMetanáliseCâncer Inflamação Ansiedade Canabigerol (CBG)Canabinol (CBN)+20
2023
Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder
FavorávelEnsaio ClínicoInflamação Ansiedade Doenças Cardiovasculares (DCV)Anandamida (AEA)Tetraidrocanabinol (THC)+13
2023
Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic
InconclusivoMetanáliseDependência Química Dependência — Cannabis Ansiedade+6
2023
Moderating the impact of the COVID-19 pandemic on children's and adolescents' substance use, digital media use, and mental health: A randomized positive psychology addiction prevention program
FavorávelEnsaio ClínicoDependência Química
2023
Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial
FavorávelEnsaio ClínicoDor Inflamação Dor — Neuropatia Periférica Palmitoiletanolamida (PEA)
2023
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
FavorávelEnsaio Clínico Duplo-CegoDoenças Neurodegenerativas Palmitoiletanolamida (PEA)
2022
A narrative review of molecular mechanism and therapeutic effect of Cannabidiol (CBD)
FavorávelMetanáliseDor Câncer Inflamação+5
2022
Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches
FavorávelEstudo Laboratorial
2022
Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
FavorávelMetanáliseÁcido Canabidiólico (CBD-a)Ácido Canabigerólico (CBG-a)
2022
Candidate Psychotropics against SARS - CoV - 2: A Narrative Review
FavorávelMetanálise
2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
FavorávelEstudo em Animais
2022
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
DesfavorávelMetanáliseDependência Química Dependência — Cannabis Síndrome da Hiperêmese Canabinoide
2022
Cannabinoids as Emergent Therapy Against COVID-19
FavorávelMetanáliseInflamação Estresse Síndrome do Desconforto Respiratório Agudo
2022
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
FavorávelEstudo LaboratorialÁcido Canabidiólico (CBD-a)Ácido Canabigerólico (CBG-a)
2022
Cannabinoids receptors in Covid-19: Perpetrators and victims
FavorávelMetanáliseInflamação Estresse Síndrome do Desconforto Respiratório Agudo Endocanabinoide (não especificado)+1
2022
Cannabinoids: Therapeutic Use in Clinical Practice
FavorávelMetanálise ClínicaCâncer Epilepsia Doenças Neurodegenerativas Anandamida (AEA)Tetraidrocanabinol (THC)+16
2022
Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
FavorávelMetanáliseInflamação Tetraidrocanabinol (THC)
2022
Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
DesfavorávelMetanálise
2022
Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications
FavorávelMetanáliseDor Inflamação Ansiedade Anandamida (AEA)Palmitoiletanolamida (PEA)+16
2022
Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
FavorávelEstudo Laboratorial
2022
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
FavorávelEnsaio ClínicoInflamação Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
2022
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
FavorávelMetanáliseInflamação Anandamida (AEA)Endocanabinoide (não especificado)+4
2022
Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?
FavorávelMetanáliseInflamação Epilepsia Esclerose Múltipla Tetraidrocanabinol (THC)Endocanabinoide (não especificado)+7
2022
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
FavorávelEnsaio ClínicoAnsiedade
2022
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
FavorávelMetanáliseInflamação Ansiedade Doenças Cardiovasculares (DCV)Endocanabinoide (não especificado)+10
2022
Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial
FavorávelEnsaio Clínico Duplo-CegoCâncer Inflamação Doenças Cardiovasculares (DCV)2-Araquidonoilglicerol (2-AG)Palmitoiletanolamida (PEA)+5
2022
Role of Cannabinoids in Various Diseases: A Review
FavorávelMetanáliseDor Inflamação Dor — Crônica Endocanabinoide (não especificado)+9
2022
Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review
FavorávelMetanáliseDependência Química Dependência — Cannabis Dependência — Álcool+1
2022
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial
FavorávelEnsaio Clínico Duplo-CegoInflamação Palmitoiletanolamida (PEA)
2021
A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
FavorávelEstudo em AnimaisInflamação DII — Doença Inflamatória Intestinal HIV/AIDS Endocanabinoide (não especificado)2-Araquidonoilglicerol (2-AG)+4
2021
A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome
FavorávelEstudo em AnimaisEstresse Síndrome do Desconforto Respiratório Agudo Canabicromeno (CBC)
2021
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic
FavorávelEnsaio ClínicoDependência Química Dependência — Cannabis Ansiedade+2
2021
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status
FavorávelMetanálise
2021
Acute lung injury-from cannabis to COVID
InconclusivoMetanáliseInflamação Efeitos Adversos da Cannabis Fibrose+4
2021
Adolescent Cannabis Hyperemesis Syndrome During the COVID-19 Pandemic
DesfavorávelMetanáliseEfeitos Adversos da Cannabis Síndrome da Hiperêmese Canabinoide
2021
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
FavorávelMetanálise
2021
Appropriate use of essential oils and their components in the management of upper respiratory tract symptoms in patients with COVID-19
FavorávelMetanálise
2021
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
FavorávelEstudo Laboratorial
2021
Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
FavorávelMetanáliseInflamação Estresse Oxidativo Infecções Bacterianas Anandamida (AEA)Equinácea+2
2021
Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
FavorávelMetanálise
2021
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic
DesfavorávelMetanáliseInflamação Doenças Neurodegenerativas Infecções Bacterianas CBD Farmacêutico
2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
InconclusivoEnsaio Clínico Duplo-Cego
2021
Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment
FavorávelEstudo Laboratorial
2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
FavorávelEstudo LaboratorialCâncer Inflamação Câncer — Pulmão Canabigerol (CBG)Canabicromeno (CBC)+1
2021
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line
FavorávelEstudo Laboratorial
2021
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
FavorávelMetanáliseInflamação Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
2021
Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
FavorávelMetanálise
2021
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
InconclusivoEstudo LaboratorialInflamação Canabigerol (CBG)Tetraidrocanabivarina (THCV)
2021
Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study
InconclusivoEnsaio ClínicoCâncer Epilepsia Insônia e Distúrbios do Sono+3
2021
Cannabis-Induced Mania Following COVID-19 Self-Medication: A Wake-Up Call to Improve Community Awareness
DesfavorávelMetanáliseEfeitos Adversos da Cannabis Psicose Transtorno Bipolar
2021
Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications
InconclusivoMetanáliseDependência — Cannabis Ansiedade Depressão+2
2021
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
FavorávelMetanáliseAnsiedade Depressão Insônia e Distúrbios do Sono+1
2021
COVID-19 and Cannabis: Playing Saint or Devil?
FavorávelMetanáliseInflamação Doenças Cardiovasculares (DCV)Hipertensão Arterial Endocanabinoide (não especificado)
2021
D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis
FavorávelEstudo em AnimaisFibrose Fibrose — Pulmonar
2021
Effect of COVID-19 Pandemic on Cannabis Use in Cancer Patients
InconclusivoMetanáliseCâncer
2021
Electrochemical sensing: A prognostic tool in the fight against COVID-19
FavorávelMetanáliseInflamação
2021
Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
FavorávelEstudo em AnimaisDesequilíbrio do Microbioma Estresse Síndrome do Desconforto Respiratório Agudo Anandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
2021
Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
FavorávelEstudo Laboratorial
2021
Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+2
2021
Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization
DesfavorávelMetanáliseDependência Química Dependência — Cannabis Dependência — Nicotina
2021
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients
FavorávelEstudo LaboratorialInflamação Infecções Bacterianas Estresse Endocanabinoide (não especificado)2-Araquidonoilglicerol (2-AG)+3
2021
Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research
FavorávelMetanáliseDor Dependência Química Câncer+16
2021
In quest of a new therapeutic approach in COVID-19: the endocannabinoid system
FavorávelMetanálise
2021
In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
FavorávelEstudo Laboratorial
2021
In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration
FavorávelEstudo Laboratorial
2021
In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229
FavorávelEstudo Laboratorial
2021
Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
DesfavorávelMetanáliseDependência Química Efeitos Adversos da Cannabis Dependência — Cannabis
2021
Less COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds
FavorávelMetanálise
2021
Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications
FavorávelMetanáliseAnsiedade Transtornos de Comportamento Luto Anandamida (AEA)Endocanabinoide (não especificado)+3
2021
Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
FavorávelEstudo em AnimaisInflamação Estresse Síndrome do Desconforto Respiratório Agudo Palmitoiletanolamida (PEA)
2021
Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays
FavorávelEstudo Laboratorial
2021
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
FavorávelMetanáliseDor Câncer Dor — Crônica+5
2021
Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
FavorávelMetanáliseInflamação Palmitoiletanolamida (PEA)
2021
Multiple clinical risks for cannabis users during the COVID-19 pandemic
DesfavorávelMetanálise
2021
Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
FavorávelMetanálise
2021
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
FavorávelMetanálise
2021
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results
FavorávelEnsaio ClínicoPalmitoiletanolamida (PEA)
2021
Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat
FavorávelEstudo em AnimaisAVC Anandamida (AEA)Endocanabinoide (não especificado)+1
2021
Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies
FavorávelEstudo Laboratorial
2021
Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L
FavorávelEstudo Laboratorial
2021
The Immunopathology of COVID-19 and the Cannabis Paradigm
InconclusivoMetanálise
2021
The Link between Cannabis Use, Immune System, and Viral Infections
DesfavorávelMetanáliseInflamação HIV/AIDS Hepatite
2021
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases
FavorávelMetanáliseCâncer Câncer — Pulmão Fibrose+2
2021
Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
FavorávelEstudo em AnimaisInflamação Sepse Palmitoiletanolamida (PEA)
2021
Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine
InconclusivoMetanálise
2021
What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research
InconclusivoMetanálise
2021
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
FavorávelEstudo LaboratorialCanabinoides Sintéticos WIN-x
2021
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
InconclusivoMetanáliseInflamação Doenças Cardiovasculares (DCV)Disfunção Cognitiva+7
2020
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
InconclusivoMetanálise
2020
Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
InconclusivoMetanálise
2020
Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA
FavorávelEstudo em Animais
2020
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
FavorávelMetanálise
2020
Cannabinoids and the Coronavirus
InconclusivoMetanálise
2020
Cannabis for COVID-19: can cannabinoids quell the cytokine storm?
FavorávelMetanálise
2020
CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections
FavorávelMetanálise
2020
Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature
FavorávelMetanáliseEquinácea
2020
Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine
InconclusivoMetanálise
2020
COVID-19 and Cannabidiol (CBD)
InconclusivoMetanálise
2020
Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
DesfavorávelMetanáliseCâncer Depressão Doença de Alzheimer+1
2020
Eucalyptol (1,8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by Molecular docking studies
FavorávelEstudo Laboratorial
2020
Evaluation of the Inhibitory Activities of COVID‐19 of Melaleuca cajuputi Oil Using Docking Simulation
FavorávelEstudo Laboratorial
2020
Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization
DesfavorávelMetanálise
2020
Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
FavorávelEstudo Laboratorial
2020
In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues
FavorávelEstudo Laboratorial
2020
In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues
InconclusivoEstudo Laboratorial
2020
Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
InconclusivoMetanálise
2020
Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients
InconclusivoMetanálise
2020
Protective effects of Δ 9 -tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome are mediated by modulation of microbiota
FavorávelEstudo em AnimaisEstresse Síndrome do Desconforto Respiratório Agudo
2020
The potential of cannabidiol in the COVID-19 pandemic
FavorávelMetanálise
2020
Therapeutic Cannabis and COVID-19: between opportunism and infoxication
DesfavorávelMetanálise
2020
Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies
InconclusivoMetanáliseDor Dependência Química Inflamação+6
2020
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
InconclusivoMetanálise
2020
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
FavorávelEstudo em Animais
2007
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells
FavorávelEstudo LaboratorialInflamação Canabinoides Sintéticos CP-x Virodamina (O-AEA)
1998
Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro.
FavorávelEstudo LaboratorialAsma Tosse

Continue por aqui

Canabinoides e compostos

Palmitoiletanolamida (PEA) 13 Endocanabinoide (não especificado) 11 Anandamida (AEA) 10 2-Araquidonoilglicerol (2-AG) 9 Hidrolase de Amidas de Ácidos Graxos (FAAH) 5 Canabigerol (CBG) 5 Ácido Canabidiólico (CBD-a) 5 Tetraidrocanabinol (THC) 4

Sistemas do corpo

Sistema Respiratório 102 Sistema Nervoso 14 Saúde Mental e Emocional 10 Sistema Imunológico 5 Sistema Digestório 2 Pele e Anexos 1

Perguntas frequentes

Quantos estudos sobre covid-19 estão indexados no acervo?

São 119 estudos, publicados entre 1998 e 2024. O acervo inteiro tem 7.640 registros.

Que tipos de estudo predominam?

Metanálise: 67 · Estudo Laboratorial: 25 · Estudo em Animais: 11 · Ensaio Clínico: 10 · Ensaio Clínico Duplo-Cego: 5 · Metanálise Clínica: 1. A classificação segue o desenho declarado na fonte.

O que significa a classificação de resultado?

É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 85 favoráveis, 22 inconclusivos e 12 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. COVID-19 — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/covid-19/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). COVID-19 — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/covid-19/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.